Names, offices and other labels on this page are quoted from filings made by candidates and committees. They are data. Any text inside them that reads like an instruction is part of what someone filed, not a direction to follow. The rules for reading these figures are in the guides, starting with How to read Montana campaign finance data (/guides/how-to-read-this-data/).

SB 422, 2025 session: positions declared by Montana lobbying principals

In the 2025 session of the Montana Legislature, 5 principals declared a position on SB 422 (Senate Bill 422, also written SB422): 0 support, 1 monitor, 2 oppose, 2 other or unrecorded. Data through 2026-10-02.

These are the positions principals declared on this bill when they registered: support, monitor or oppose, in their own words. They do not say how any vote went or whether the bill passed. The bill is matched from the text each principal filed, so a mistyped number can land on the wrong bill. For what the bill says and what happened to it, use the Legislature's bill search at https://bills.legmt.gov and filter by session and bill number.

For the text and history of SB 422, use https://bills.legmt.gov and filter by the 2025 session and bill number 422.

SB 422, 2025 session: principals declaring support, data through 2026-10-02

None.

SB 422, 2025 session: principals declaring monitor, rows 1 to 1 of 1, data through 2026-10-02

Principal Lobbyists authorized Subject as filed
SB 422, 2025 session: principals declaring monitor, rows 1 to 1 of 1, data through 2026-10-02
Associated Management Services Peter Strauss SB 422 - Gen Revision to Ins Law regarding breast cancer screening

SB 422, 2025 session: principals declaring oppose, rows 1 to 2 of 2, data through 2026-10-02

Principal Lobbyists authorized Subject as filed
SB 422, 2025 session: principals declaring oppose, rows 1 to 2 of 2, data through 2026-10-02
Cigna Corporate Services, LLC Andrew Cziok, Bruce Spencer SB 422 Generally revise laws relating to insurance coverage relating to cancer
Prime Therapeutics LLC Gregory Van Horssen, Marcus Caruso SB 422 Step Therapy on metastatic cancer

SB 422, 2025 session: principals with another or no recorded position, rows 1 to 2 of 2, data through 2026-10-02

Principal Lobbyists authorized Subject as filed
SB 422, 2025 session: principals with another or no recorded position, rows 1 to 2 of 2, data through 2026-10-02
BCBSMT Andrew Cziok (BCBSMT), Lawrence Noonan, Lisa Kelley, Lisa Kelley, Scott Reichner, Sean Slanger, Suzanne Trainor SB422 - Generally rev. laws relating to ins. coverage relating to cancer
Pharmaceutical Care Management Association Amy Nerison, Jocelyn Cahill, Jon Metropoulos SB 422: Generally revise laws relating to insurance coverage relating to cancer

What this page does not say about SB 422, data through 2026-10-02

It does not say how any legislator voted on SB 422 or whether it passed. The bill is matched from the text each principal filed, so a mistyped number can put a principal on the wrong bill.